Status:

RECRUITING

Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Helicobacter Pylori Infection

Premalignant Lesion

Eligibility:

All Genders

20-80 years

Brief Summary

The aim of this diagnostic accuracy study is to evaluate the application of artificial intelligence on the diagnosis of Helicobacter pylori infection and premalignant gastric lesions based on upper en...

Detailed Description

This study had invited patients to undergo urea breath test, upper gastrointestinal endoscopy, and histology examination. The study will collect their tests results, upper gastrointestinal endoscopy i...

Eligibility Criteria

Inclusion Criteria:

  1. Age 20-80
  2. Scheduled urea breath test and endoscopy

Exclusion Criteria:

1. History of gastric surgery

Key Trial Info

Start Date :

December 24 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT05762991

Start Date

December 24 2021

End Date

December 31 2026

Last Update

June 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yi-Chia Lee

Taipei, Taiwan, 10015

Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion | DecenTrialz